Safety of anti-TNFa biological drugs
Objective: To analyse TNF-a antagonists (infliximab, etanercept e adalimumab) side effects published in the literature. Methods: Review of published studies on this matter. Results: The main side effects reported include severe infections (even though such a risk is increased per se in RA patients),...
Saved in:
Main Authors: | G. Valentini (Author), F. Trotta (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are there differences among anti-TNFa biological drugs?
by: G. Valesini
Published: (2011) -
Biologic therapy with anti-TNFa in rheumathoid atrhritis
by: G. Ferraccioli
Published: (2011) -
Approved indications and other possible utilizations of anti-TNFa biologic drugs
by: C. Montecucco, et al.
Published: (2011) -
Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases
by: G. Lapadula
Published: (2011) -
Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
by: P. Airò, et al.
Published: (2011)